Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FANCE | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ZDHHC9 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | FEM1A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | EQTN | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
mRNA | NEURL1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | PYHIN1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | SNAPC4 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | VPS36 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | TMEM81 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | UBE2K | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |